Cardiovascular • May 1-3, 2017
Boston, MA • United States

World Medical Innovation Forum 2017: The Future of Cardiovascular Care

Anthony Rosenzweig, MD, chief of cardiology and co-director of the Corrigan Minehan Heart Center at MGH, describes a paradox at the center of heart disease. On the one hand, the last half-century has seen a dramatic drop in death rates among patients hospitalized for a heart attack. On the other hand, survivors often go on…

Read More

Calum MacRae, MD, PhD: One Brave Heart

Musing over the proposal that netted him a $75 million “One Brave Idea” prize from the American Heart Association, Calum MacRae, MD, PhD, recognizing the many applicants for the grant, credits good luck and strong collaborations over ingenuity. “I think the funders were brave to give us the money.” Nevertheless, MacRae, chief of cardiovascular medicine…

Read More

Day Three Highlights

Highlights of the Day Day Three of the World Medical Innovation Forum was short, but was filled with some of the most exciting aspects of the meeting. The first session touched on the needs of cancer patients who require alternative strategies to achieve optimal therapeutic benefit, and the advantages and challenges associated with combination therapy.…

Read More

Day Two Highlights

Highlights of the Day Day Two of the World Medical Innovation Forum was brimming with fireside chats and panel discussions. The first session of the day highlighted the growing global cancer burden in which panelists from leading international companies and key government entities discussed the challenges to providing innovative technologies in diverse markets, as well…

Read More

Day One Highlights

    Day One of the World Medical Innovation Forum began with a wave of young investigators highlighting promising developments in cancer research in a series of rapid-fire presentations. Recurring themes of the First Look session included the use of RNA in-situ hybridization (RNA-ISH) as a diagnostic tool, liquid biopsies for exosome analysis, and precision…

Read More

Kathy Giusti: A Profile in Innovation

What if choosing the very best treatment for any given cancer were as routine as choosing the right kind of antibiotic to treat a common infection? Kathy Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), and a cancer patient herself, has made it her personal mission. She foresees the day when an individual’s medical…

Read More

Social Media at WMIF 2016: Engage with Us!

World Medical Innovation Forum 2016 is quickly approaching! Would you like to engage with us throughout the Forum and hear about all of the speakers, panels and presentations? If so, connect with us on Twitter and lookout for our blog posts. Our blog will provide daily roundups of the Forum and keep you informed about…

Read More

A Second Glimpse at First Look: The Next Wave of Cancer Breakthroughs.

A Second Glimpse at First Look: The Next Wave of Cancer Breakthroughs. For our last blog feature, we spoke with Alexander Lin, PhD, Director of the Center for Clinical Spectroscopy at Brigham and Women’s Hospital and Assistant Professor of Radiology at Harvard Medical School, and gave you a preview of his upcoming First Look presentation,…

Read More

First Look: The Next Wave of Cancer Breakthroughs

The World Medical Innovation Forum is excited to launch First Look: The Next Wave of Cancer Breakthroughs. During this session, which opens the Forum on Monday, April 25, we will hear from a wide variety of creative minds on their most promising commercially related research, and what drives their passions every day. These rapid-fire presentations…

Read More

World Medical Innovation Forum Day 3 Recap

The final day of the inaugural Partners HealthCare World Medical Innovation Forum was a fittingly profound end to a thought-provoking meeting that featured leaders from business, research, and clinical practice discussing the most important and relevant topics of the day related to healthcare and brain disease. Reshaping Innovation Through Electronic Health The day began with…

Read More

Day 3 Disruptive Dozen Overview

A powerful summary of many of the innovations discussed at the Forum the past 3 days, the “Disruptive Dozen” is more than just a registry of buzz words; this list represents the optimistic current state of neuroscience and one to look back on in years to come to see the progress made. 12. DIAGNOSING AND…

Read More

Day Two – Focus Group Wrap Ups

National Security Through Neurodevelopment: County Initiatives to Meet CNS Challenges Neurodegenerative and neuropsychiatric diseases threaten the United States and wide swaths of the globe. Alzheimer’s disease (AD), alone — where 120 million across the world may be affected by mid-century — may cost trillions of dollars. The economic burden on families and governments will be…

Read More

World Forum – Day 2 Recap

The second day of the World Medical Innovation Forum continued to build momentum on the Forum’s mission — providing a venue for imperative conversation among academic, private, government and patient/consumer communities. The agenda set forth today brought together stakeholders across disciplines — patients living with neurologic conditions and leaders in academic medical research, private biotechnology,…

Read More

World Forum – Day 1 Recap

Partners HealthCare kicked off its inaugural World Medical Innovation Forum in Boston on April 27 with a truly international presence, bringing together over 1,000 attendees from 18 countries to discuss and advance the state of neuroscience research, patient care, and delivery. The first day of this three-day event also highlighted the role of collaboration and…

Read More

Reflections on Day 1 of the World Medical Innovation Forum

The almost $700 billion annual spend in neurodegenerative diseases tells a story of a global community struck by an array of stubborn neurological conditions and challenged by drug discovery, delivery, care, regulatory protocols, and economic and organizational practices serving at cross-purposes. Yet, there was something inspirational and I dare say hopeful about the presenters’ opinions…

Read More

New Hopes for Alzheimer’s disease featured at World Medical Innovation Forum

New Hopes for Alzheimer’s disease featured at World Medical Innovation Forum Six Reasons why the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (the “A4 study”) with Reisa Sperling, MD, BWH, Director of Clinical Research, Memory Disorders Unit, Brigham and Women’s Hospital is making Strides 1. The novel concept of treating patients before they are symptomatic Instead…

Read More

Spotlighting Innovation at Our Inaugural Forum

Throughout the United States, every phase of healthcare is being fundamentally restructured. As these changes take place, the need for disruptive research and applied innovation will remain an enduring priority. Partners HealthCare, as the largest single academic research entity, is convening leaders from around the globe to consider the future of collaborative innovation as part…

Read More